Horrific 2nd Quarter sales results in!!

Discussion in 'Esperion' started by anonymous, Aug 3, 2021 at 3:24 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    10.6 million in net sales!! Wow is all we can say. Still no growth for BA as Esperions lifeline of cash from DS is keeping company afloat. Moody and Sheldon have failed miserably in their short time at Esperion. The salesforce continues to stumble through offices begging for scripts. If nobody is working on their Plan B then your in for rough ride that will not end well.
     

  2. anonymous

    anonymous Guest

    This was well rehearsed as usual on the call. All the questions had been screened and planted. A great deal of dancing around the low amount of scripts and 10.6 mil in net revenue. Pretty poor. The management team made out like this was a scene from Gladiator with all there talk of momentum. The Sanofi retread Warren they brought in was very weak. He should stick to pharmacy as he can't lead the troops.
     
  3. anonymous

    anonymous Guest

    Well there’s no question that the upturn continues and the future looks brighter. Clearly a tactical error was made in turning off cover my meds as many scripts were left on the table. The only real issue ahead is Covid right now as clearly that slammed the launch and may prove to be a barrier going forward. I am staying the course with my head up and pride intact.
     
  4. anonymous

    anonymous Guest

    Of course you are. Why shouldn't you keep your head up and pride intact after posting pathetic script numbers for the quarter. As usual your ready to throw out the white flag with Covid as you did last year. The company is still in business because of the loans. Sooner or later DS and the other lending houses will want their money back. Esperion sales aren't even covering the salesforce or management salaries. The dinner programs have been a joke and the Humana situation is comical. Listening to Warren talk is like listening to a bedtime story from a creepy uncle. How could anyone in their right mind say this was a positive quarter. If it was so rosey why did the stock take a dump. Will see what happens with the stock tomorrow and the rest of the week. Not one word today on why the stock has gone from 78.00 to 14.00 in one year. This wasn't good.
     
  5. anonymous

    anonymous Guest

    Will see how the market responds to this flaccid earnings call from yesterday. There still making excuses with Covid despite multiple companies doing 50-90 million per quarter in sales. And these are companies who launched at same time as BA.